Key Financial Data Of Group

Delta-Fly Pharma, Inc. - Filing #7574302

Concept As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2021-12-31
2021-10-01 to
2021-12-31
2021-04-01 to
2021-12-31
Key financial data of group
Business results of group
Ordinary profit (loss)
-1,035,896,000 JPY
-964,064,000 JPY
-835,111,000 JPY
Net assets
750,728,000 JPY
1,233,161,000 JPY
1,362,935,000 JPY
Total assets
952,899,000 JPY
1,324,352,000 JPY
1,441,458,000 JPY
Basic earnings (loss) per share
-190.18
-75.04
-178.58
-51.68
-154.65
Diluted earnings per share
Equity-to-asset ratio
0.784 xbrli:pure
0.931 xbrli:pure
0.945 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.